Josephine Mollon , Nuria Lanzagorta , Samuel R Mathias , Amanda Rodrigue , Emma E.M. Knowles , Emma Deaso , Laura Cadavid , Jimena Unzueta Saavedra , Catherine Brownstein , Eugene D'Angelo , Joseph Gonzalez-Heydrich , Patricia Zavaleta Ramírez , Emmanuel Sarmiento , Carlos Bustamante , Christopher A. Walsh , Laura Almasy , Humberto Nicolini , David C. Glahn
{"title":"The burden of early onset psychosis: Diagnostic complexity, high comorbidity, and poor functioning in patients and their relatives","authors":"Josephine Mollon , Nuria Lanzagorta , Samuel R Mathias , Amanda Rodrigue , Emma E.M. Knowles , Emma Deaso , Laura Cadavid , Jimena Unzueta Saavedra , Catherine Brownstein , Eugene D'Angelo , Joseph Gonzalez-Heydrich , Patricia Zavaleta Ramírez , Emmanuel Sarmiento , Carlos Bustamante , Christopher A. Walsh , Laura Almasy , Humberto Nicolini , David C. Glahn","doi":"10.1016/j.schres.2025.09.022","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The Early Psychosis Investigation Centers in Mexico (EPIMex) and Boston (EPICenter) recruit children and adolescents with early onset psychosis (EOP), their relatives, and controls to elucidate risk factors for EOP.</div></div><div><h3>Methods</h3><div>In Mexico, data were available for 860 EOP probands, 493 relatives, and 865 controls, and in Boston, for 120 EOP probands, 182 relatives, and 60 controls. Psychiatric diagnoses were ascertained using the Structured Clinical Interview for the DSM-V (SCID-5). General cognitive ability was calculated using 7 cognitive tests. Functioning and symptoms were ascertained with the Children's Global Assessment Scale or Global Assessment of Functioning scale, and the Brief Psychiatric Rating Scale, respectively. EOP probands, relatives with and without diagnoses, and controls with nonpsychotic diagnoses were compared to controls without diagnoses.</div></div><div><h3>Results</h3><div>In Mexico, over 86 % of EOP probands had at least one psychiatric comorbidity, and 73 % of relatives had a psychiatric diagnosis, with 52 % having multiple diagnoses. In Boston, 77 % of EOP probands had at least one psychiatric comorbidity, and 80 % of relatives had a psychiatric diagnosis, with 42 % having multiple diagnoses. In Mexico, EOP probands, and relatives showed small cognitive deficits (effect size (ES) = 0.22–0.29, <em>p</em> < .05). In Boston, all groups showed large cognitive deficits (ES = 0.82–1.28, <em>p</em> = .001). Across both sites, all diagnostic groups (EOP probands, relatives and controls with diagnoses) showed poor functioning (ES = 0.87–1.92, <em>p</em> < .001), and severe symptoms (ES = 0.52–1.71, <em>p</em> < .02), and only 17 % of EOP probands showed “good” functioning (GAF/CGAS>70).</div></div><div><h3>Conclusions</h3><div>Early onset psychosis (EOP) is associated with high comorbidity, and poor functioning in patients, and their relatives.</div></div>","PeriodicalId":21417,"journal":{"name":"Schizophrenia Research","volume":"285 ","pages":"Pages 165-174"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0920996425003329","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The Early Psychosis Investigation Centers in Mexico (EPIMex) and Boston (EPICenter) recruit children and adolescents with early onset psychosis (EOP), their relatives, and controls to elucidate risk factors for EOP.
Methods
In Mexico, data were available for 860 EOP probands, 493 relatives, and 865 controls, and in Boston, for 120 EOP probands, 182 relatives, and 60 controls. Psychiatric diagnoses were ascertained using the Structured Clinical Interview for the DSM-V (SCID-5). General cognitive ability was calculated using 7 cognitive tests. Functioning and symptoms were ascertained with the Children's Global Assessment Scale or Global Assessment of Functioning scale, and the Brief Psychiatric Rating Scale, respectively. EOP probands, relatives with and without diagnoses, and controls with nonpsychotic diagnoses were compared to controls without diagnoses.
Results
In Mexico, over 86 % of EOP probands had at least one psychiatric comorbidity, and 73 % of relatives had a psychiatric diagnosis, with 52 % having multiple diagnoses. In Boston, 77 % of EOP probands had at least one psychiatric comorbidity, and 80 % of relatives had a psychiatric diagnosis, with 42 % having multiple diagnoses. In Mexico, EOP probands, and relatives showed small cognitive deficits (effect size (ES) = 0.22–0.29, p < .05). In Boston, all groups showed large cognitive deficits (ES = 0.82–1.28, p = .001). Across both sites, all diagnostic groups (EOP probands, relatives and controls with diagnoses) showed poor functioning (ES = 0.87–1.92, p < .001), and severe symptoms (ES = 0.52–1.71, p < .02), and only 17 % of EOP probands showed “good” functioning (GAF/CGAS>70).
Conclusions
Early onset psychosis (EOP) is associated with high comorbidity, and poor functioning in patients, and their relatives.
期刊介绍:
As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!
Schizophrenia Research''s time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.
The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.